1. Response to Cardiac Resynchronization Therapy Across Chronic Kidney Disease Stages

   Ter Maaten, J. M., Martens, P., L'Hoyes, W., Maass, A. H., Damman, K., Dupont, M. & Mullens, W., Oct-2019, In : JOURNAL OF CARDIAC FAILURE. 25, 10, p. 803-811 9 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Fully automated QRS area measurement for predicting response to cardiac resynchronization therapy

   Plesinger, F., van Stipdonk, A. M. W., Smisek, R., Halamek, J., Jurak, P., Maass, A. H., Meine, M., Vernooy, K. & Prinzen, F. W., 9-Jul-2019, In : Journal of Electrocardiology. 5 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. PR interval prolongation, still a marker of worse outcome in patients treated cardiac resynchronization therapy patients

   Van Stipdonk, A. M. W. A. M. W., Dural, M., Salden, F., Ter Horst, I. A. H., Crijns, H. J. G. M., Prinzen, F. W., Meine, M., Maass, A. H. & Vernooy, K., May-2019, In : European Journal of Heart Failure. 21, p. 373 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

4. Baseline characteristics determine long-term outcome to CRT, intermediate endpoints identify those at risk of adverse events.

   Van Stipdonk, A. M. W. A. M. W., Ghossein, M., Kloosterman, M., Ter Horst, I. A. H., Prinzen, F. W., Meine, M., Vernooy, K. & Maass, A. H., May-2019, In : European Journal of Heart Failure. 21, p. 374 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

5. Response to cardiac resynchronization therapy is present across all stages of chronic kidney disease

   Ter Maaten, J. M. J., Martens, P., Maass, A. H., Damman, K., Dupont, M. & Mullens, W., May-2019, In : European Journal of Heart Failure. 21, p. 347 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

View all (126) »